NextNav Inc.
NN · NASDAQ
Analyst ratings
strong_buy · 1 ratings
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| June 3, 2026 | Oppenheimer | Maintains | Outperform | $50.00 |
FCC regulatory approval and spectrum valuation potential
NextNav's 900 MHz spectrum petition has strong backing from incoming FCC Chair Brendan Carr and other Commissioners, with spectrum alone potentially valued at ~$40 per share if approval is granted. The market's binary view of the FCC petition is flawed, as negotiations and compromises remain viable pathways to a favorable outcome.
Regulatory delays in the PNT space remain a key near-term risk for NextNav. Despite long-term AI and national security demand tailwinds, the FCC approval timeline is uncertain and could continue to weigh on the stock, which is already trading far below analyst consensus price targets.
Revenue trajectory and path to profitability
Oppenheimer doubled its price target on NextNav to $50, maintaining an Outperform rating, and the analyst consensus average target sits at $39.50 — implying over 200% upside from current prices. Earnings per share are forecast to grow at 29.3% annually, signaling improving operational leverage over time.
NextNav's revenue is expected to decline at 12.5% per year over the next three years, and the company is forecast to remain unprofitable through at least 2027. Analyst models show deepening net losses, with earnings projected at -$112 million by end of 2027, raising serious concerns about the sustainability of its cash burn.
Acquisition potential and strategic value of sub-GHz spectrum assets
Oppenheimer identified NextNav as a potential acquisition target due to its sub-GHz spectrum holdings, a strategically scarce asset with significant national security and 5G implications. With 81.82% of covering analysts recommending a Buy and an average target of $39.50, institutional sentiment around NextNav's strategic value remains strongly positive.
Despite the acquisition narrative, NextNav's stock score ranks in the 20–30th percentile of its historical range, with technical indicators including RSI at 27 and a negative MACD all signaling elevated risk. Private equity-driven share sales have already pressured the stock, and no concrete acquisition bid has materialized to validate the premium valuation thesis.